Leucocyte-Rich Platelet-Rich Plasma Treatment of Gluteus Medius and Minimus Tendinopathy: A Double-Blind Randomized Controlled Trial With 2-Year Follow-up

この研究はハイインパクトの可能性があります。 OEのAI駆動型ハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文が持つ可能性の高い影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することが可能になり、読者は将来の診療を形成する可能性が最も高い論文に集中することができます。

80 patients with grade 2-3 gluteal tendinopathy were randomized to an intratendinous injection of either leukocyte-rich platelet rich plasma or corticosteroid. Patients were initially followed-up over the first 24 weeks after injection, after which they were given the option of secondary injection with LR-PRP if they had an unsatisfactory response to the first injection. Modified Harris Hip Score were significantly greater in the LR-PRP group compared to the CS group at 12 and 24 weeks, and at 52 and 104 weeks among patients who remained in their originally allocated group. A total of 27 patients of the CS group requested secondary injection with LR-PRP. After 104 weeks, 2 patients in the LR-PRP group and 3 patients in the CS group were referred for surgical intervention.